NCT07298369

Brief Summary

In partnership with Monroe, this EEG neurofeedback study is looking at the efficacy of Neuphoria with Monroe for mental clarity and well-being.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
5mo left

Started Sep 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress62%
Sep 2025Sep 2026

Study Start

First participant enrolled

September 25, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 5, 2025

Completed
18 days until next milestone

First Posted

Study publicly available on registry

December 23, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 25, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 25, 2026

Last Updated

December 23, 2025

Status Verified

December 1, 2025

Enrollment Period

1 year

First QC Date

December 5, 2025

Last Update Submit

December 19, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • EEG Spectral Power by Frequency Band

    Electroencephalography (EEG) will be used to quantify spectral power across standard frequency bands (delta \[1-4 Hz\], theta \[4-8 Hz\], alpha \[8-12 Hz\], beta \[12-30 Hz\]). Power values will be derived using proprietary signal processing algorithms and summarized as relative power per band.

    Change from baseline (Day 1-7) in cognitive profile metrics at 4 to 5 weeks after the start of the intervention

  • Perceived Stress Scale (Past Week Version)

    The Perceived Stress Scale (Past Week Version) is a modified version of the classic stress assessment tool that evaluates stress levels based on recent experiences within the last week. This scale helps in understanding how various situations have recently affected an individual's feelings and perceived stress levels. By focusing on a shorter time frame, it provides a more immediate assessment of stress, which can be particularly useful for quickly evaluating the effectiveness of stress management strategies or interventions. The tool retains its original structure, ensuring its reliability while making it more relevant for current stress evaluation. Score Range Minimum: 0 Maximum: 40 Interpretation Higher scores indicate worse outcomes, reflecting greater perceived stress over the past week.

    Change from baseline (Day 1-3) in perceived stress levels at 4 to 5 weeks after the start of the intervention

  • Freiburg Mindfulness Inventory

    The Freiburg Mindfulness Inventory (FMI) is a valid and reliable questionnaire designed to measure mindfulness. The 14 items in the inventory cover all aspects of mindfulness. Participants are asked to reflect on their experiences over a certain period of time and answer each statement as honestly and spontaneously as possible. There are no 'right' or 'wrong' answers, the focus is solely on personal experience. Score Range The range depends on the version used: 14-item version (FMI-14): Minimum: 14 Maximum: 56 Interpretation Higher scores indicate better outcomes, reflecting greater levels of mindfulness. Lower scores indicate lower mindfulness.

    Change from baseline (Day 1-3) in mindfulness levels at 4 to 5 weeks after the start of the intervention

  • EEG-Derived Cognitive State Index

    A composite cognitive state index derived from EEG spectral features, reflecting participant alertness and engagement. The index is calculated using a proprietary algorithm and reported on a normalized scale.

    Change from baseline (Day 1-7) in cognitive profile metrics at 4 to 5 weeks after the start of the intervention

Study Arms (1)

Single arm where participants act as their own control

EXPERIMENTAL

Single arm where participants act as their own control

Device: Neuphoria Wearable

Interventions

Neuphoria wearable measures Electroencephalography (EEG) brainwaves.

Single arm where participants act as their own control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Can read and understand English.
  • US resident.
  • Willing and able to follow the requirements of the protocol.

You may not qualify if:

  • Individuals with severe mental health disorders
  • Individuals with low frustration tolerance
  • Individuals without access to emergency medical care
  • Individuals involved in regulated professions
  • Individuals with skepticism towards digital monitoring
  • Individuals without a support system

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Efforia

New York, New York, 10003, United States

RECRUITING

Related Links

MeSH Terms

Conditions

Psychological Well-Being

Condition Hierarchy (Ancestors)

Personal SatisfactionBehavior

Central Study Contacts

Matthew Amsden

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Model Details: Single Arm observational where participants act as their own control
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 5, 2025

First Posted

December 23, 2025

Study Start

September 25, 2025

Primary Completion (Estimated)

September 25, 2026

Study Completion (Estimated)

September 25, 2026

Last Updated

December 23, 2025

Record last verified: 2025-12

Locations